Cytokinetics grants inducement stock options and RSUs under Nasdaq rule
Cytokinetics said inducement grants were made on Sept. 15, 2026: stock options for 52,834 shares and RSUs for 35,025 shares to be settled in common stock.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.